Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT01745354 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Accrual issues - Slow accrual

Conditions

Lymphoma, Non-Hodgkin
Hodgkin Disease

Interventions

DRUG: SD-101
RADIATION: Local Radiation

Sponsor

Robert Lowsky